Physician profile
Stella Geller
NPI 1811910219
$2,278.34
in general payments reported to CMS, 2019-2025
17 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $380 · 2021: $534 · 2022: $372 · 2023: $275 · 2024: $228 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $584.30 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $398.44 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $297.53 | 2019-2024 | Trulance |
| Janssen Pharmaceuticals, INC | $271.40 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $121.33 | 2021-2024 | Linzess |
| Lilly USA, LLC | $112.93 | 2020-2024 | Mounjaro, Zepbound |
| Aimmune Therapeutics, INC. | $78.05 | 2024 | |
| Allergan, INC. | $70.85 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $69.27 | 2019-2021 | |
| Amarin Pharma, INC. | $56.43 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $55.92 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $43.04 | 2021 | |
| Pfizer INC. | $40.77 | 2019 | |
| Amgen INC. | $22.92 | 2020 | |
| Shield Therapeutics INC | $19.44 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $19.05 | 2025 | Gvoke Hypopen |
| Astrazeneca Pharmaceuticals Lp | $16.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stella Geller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.